An alternative schedule of oral vinorelbine tested as 2nd-line treatment on elderly patients with advanced non-small cell lung cancer (NSCLC): A phase I feasibility trial
2005 ◽
Vol 23
(16_suppl)
◽
pp. 7328-7328
Keyword(s):
Phase I
◽